Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.57%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ3.07 Billion

According to Galapagos NV's latest financial reports the company has โ‚ฌ3.07 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ3.11 B-15.39%
2023-12-31โ‚ฌ3.68 B-10%
2022-12-31โ‚ฌ4.09 B-12.95%
2021-12-31โ‚ฌ4.70 B-8.88%
2020-12-31โ‚ฌ5.16 B-10.71%
2019-12-31โ‚ฌ5.78 B347.85%
2018-12-31โ‚ฌ1.29 B12.13%
2017-12-31โ‚ฌ1.15 B18.29%
2016-12-31โ‚ฌ0.97 B185.98%
2015-12-31โ‚ฌ0.34 B81.3%
2014-12-31โ‚ฌ0.18 B35.85%
2013-12-31โ‚ฌ0.13 B45.99%
2012-12-31โ‚ฌ94.64 M190.73%
2011-12-31โ‚ฌ32.55 M-19.41%
2010-12-31โ‚ฌ40.39 M-14.76%
2009-12-31โ‚ฌ47.39 M73.49%
2008-12-31โ‚ฌ27.31 M-44.59%
2007-12-31โ‚ฌ49.29 M-4.32%
2006-12-31โ‚ฌ51.51 M118.14%
2005-12-31โ‚ฌ23.61 M129.87%
2004-12-31โ‚ฌ10.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
โ‚ฌ7.02 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.97 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ4.87 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ63.89 M-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.64 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ3.81 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ15.64 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA